Pure Global

Efficacy Classification Prediction of the Effects of Acupuncture on Abdominal Pain in Patients With Crohn's Disease - Trial NCT06352164

Access comprehensive clinical trial information for NCT06352164 through Pure Global AI's free database. This phase not specified trial is sponsored by Shanghai Institute of Acupuncture, Moxibustion and Meridian and is currently Completed. The study focuses on Crohn Disease. Target enrollment is 55 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06352164
Completed
other
Trial Details
ClinicalTrials.gov โ€ข NCT06352164
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Efficacy Classification Prediction of the Effects of Acupuncture on Abdominal Pain in Patients With Crohn's Disease
Predicting the Clinical Efficacy of Acupuncture for Abdominal Pain in Patients With Crohn's Disease Based on Gut Microbiology and Machine Learning

Study Focus

Crohn Disease

Acupuncture treatment

Interventional

other

Sponsor & Location

Shanghai Institute of Acupuncture, Moxibustion and Meridian

Shanghai, China

Timeline & Enrollment

N/A

Mar 01, 2015

Mar 31, 2024

55 participants

Primary Outcome

Characterisation of gut microflora strains predictive of acupuncture efficacy

Summary

Machine learning algorithms are applied to discover gut flora markers that predict the
 clinical efficacy of acupuncture, so as to screen the appropriate population for acupuncture
 and optimise the allocation of healthcare resources.

ICD-10 Classifications

Crohn disease, unspecified
Other Crohn disease
Crohn disease of large intestine
Crohn disease of small intestine
Crohn disease [regional enteritis]

Data Source

ClinicalTrials.gov

NCT06352164

Non-Device Trial